283 related articles for article (PubMed ID: 36331947)
21. Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.
Mei WJ; Wang XZ; Li YF; Sun YM; Yang CK; Lin JZ; Wu ZG; Zhang R; Wang W; Li Y; Zhuang YZ; Lei J; Wan XB; Ren YK; Cheng Y; Li WL; Wang ZQ; Xu DB; Mo XW; Ju HX; Ye SW; Zhao JL; Zhang H; Gao YH; Zeng ZF; Xiao WW; Zhang XP; Zhang X; Xie E; Feng YF; Tang JH; Wu XJ; Chen G; Li LR; Lu ZH; Wan DS; Bei JX; Pan ZZ; Ding PR
Ann Surg; 2023 Apr; 277(4):557-564. PubMed ID: 36538627
[TBL] [Abstract][Full Text] [Related]
22. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis.
Turri G; Ostuzzi G; Vita G; Barresi V; Scarpa A; Milella M; Mazzarotto R; Ruzzenente A; Barbui C; Pedrazzani C
JAMA Netw Open; 2024 Jun; 7(6):e2414702. PubMed ID: 38833249
[TBL] [Abstract][Full Text] [Related]
24. Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials.
Owens PW; Saeed M; McCawley N; Loughlin P; Kearney DE; Burke JP; McNamara DA; Sahebally SM
Surgeon; 2024 Jun; 22(3):166-173. PubMed ID: 38521683
[TBL] [Abstract][Full Text] [Related]
25. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
26. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
28. Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis.
Ma Z; Tan L; Liu ZL; Xiao JW
Front Surg; 2022; 9():911538. PubMed ID: 36090336
[TBL] [Abstract][Full Text] [Related]
29. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
Jacobs L; van der Vlies E; Ten Bokkel Huinink D; Bloemendal H; Intven M; Smits AB; Weusten BLAM; Siersema PD; van Lelyveld N; Los M
Clin Colorectal Cancer; 2018 Sep; 17(3):179-186. PubMed ID: 29661620
[TBL] [Abstract][Full Text] [Related]
30. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
[TBL] [Abstract][Full Text] [Related]
31. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
[TBL] [Abstract][Full Text] [Related]
32. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
33. Is Early Initiation of Adjuvant Chemotherapy Beneficial for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Radical Surgery?
Sun Y; Huang Z; Zhang Y; Lin H; Lu X; Huang Y; Chi P
World J Surg; 2020 Sep; 44(9):3149-3157. PubMed ID: 32415467
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis.
Liang Z; Chen T; Li W; Lai H; Li L; Wu J; Zhang H; Fang C
Medicine (Baltimore); 2024 Jan; 103(3):e36785. PubMed ID: 38241577
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
Ryan ÉJ; O'Sullivan DP; Kelly ME; Syed AZ; Neary PC; O'Connell PR; Kavanagh DO; Winter DC; O'Riordan JM
Br J Surg; 2019 Sep; 106(10):1298-1310. PubMed ID: 31216064
[TBL] [Abstract][Full Text] [Related]
36. Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
Wang Y; Shen L; Wan J; Zhang H; Wu R; Wang J; Wang Y; Xu Y; Cai S; Zhang Z; Xia F
BMC Cancer; 2022 Mar; 22(1):274. PubMed ID: 35291966
[TBL] [Abstract][Full Text] [Related]
37. Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial).
Yang Z; Zhang X; Zhang J; Gao J; Bai Z; Deng W; Chen G; An Y; Liu Y; Wei Q; Han J; Li A; Liu G; Sun Y; Kong D; Yao H; Zhang Z
BMC Cancer; 2022 Apr; 22(1):462. PubMed ID: 35477432
[TBL] [Abstract][Full Text] [Related]
38. Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer: A Comparison of Short- and Long-term Oncologic Outcomes.
Goffredo P; Khan A; Mott SL; Jensen CC; Madoff RD; Gaertner WB; You YN; Hassan I
Ann Surg; 2022 Dec; 276(6):e819-e824. PubMed ID: 34353995
[TBL] [Abstract][Full Text] [Related]
39. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]